Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | MPI | P34949 | 1/20 | 0.33 |
| ▸ | PGD | P52209 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL624112 | 0.82 | MPI (0.37) | MPI | |
| SCHEMBL419463 | 0.82 | MPI (0.37) | MPI | |
| Lactic Acid SCHEMBL2582472 | 0.81 | TP53 (0.37) | MPI | |
| Bicarbonate SCHEMBL8384988 | 0.80 | MPI (0.36) | MPI | |
| Bicarbonate SCHEMBL8384375 | 0.80 | MPI (0.36) | MPI | |
| SCHEMBL19951545 | 0.80 | PDE4A (0.61) | PDE4ATSHRHTTPGD | |
| SCHEMBL1162410 | 0.80 | PDE4A (0.61) | PDE4ATSHRHTTPGD | |
| SCHEMBL8937118 | 0.79 | MPI (0.35) | MPI | |
| SCHEMBL424017 | 0.79 | MPI (0.35) | MPI | |
| SCHEMBL6863025 | 0.79 | MPI (0.35) | MPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106631779-B | Polyol esters and their use in processing halogenated vinyl polymers | 济南金昌树新材料科技有限公司 | 2020-07-14 | — | — | CN | disclosed |
| US-8865229-B2 | Marrubiin and composition for reducing snoring, package and method | PURANOX MEDICAL B.V. (NL) | 2014-10-21 | — | — | US | disclosed |
| US-20110305780-A1 | Marrubiin and composition for reducing snoring, package and method | PURANOX MEDICAL B.V. (NL) | 2011-12-15 | — | — | US | disclosed |
| US-20080305192-A1 | Marrubiin and Composition For Reducing Snoring, Package and Method | PURANOX MEDICAL B.V. (NL) | 2008-12-11 | — | — | US | disclosed |
| CN-1427013-A | Self-viscous cationic or amphoteric free-radical polymer and their use in cosmetics | OREAL (FR) | 2003-07-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080305192-A1 | Marrubiin and Composition For Reducing Snoring, Package and Method | NISCH, UTRN, MTPN | PDE4A 217/4885TSHR 2388/4885HTT 2044/4885 |
| US-20110305780-A1 | Marrubiin and composition for reducing snoring, package and method | NISCH, UTRN, MTPN | PDE4A 172/4885TSHR 2744/4885HTT 2129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.